LANZATECH GLOBAL INC (LNZA)

US51655R1014 - Common Stock

1.93  +0.25 (+14.88%)

Premarket: 2.07 +0.14 (+7.25%)

Fundamental Rating

2

LNZA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 82 industry peers in the Commercial Services & Supplies industry. LNZA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LNZA is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

LNZA had negative earnings in the past year.
In the past year LNZA has reported a negative cash flow from operations.

1.2 Ratios

LNZA has a worse Return On Assets (-59.85%) than 93.83% of its industry peers.
LNZA has a Return On Equity of -951.21%. This is amonst the worse of the industry: LNZA underperforms 93.83% of its industry peers.
Industry RankSector Rank
ROA -59.85%
ROE -951.21%
ROIC N/A
ROA(3y)-19.35%
ROA(5y)N/A
ROE(3y)-40.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 44.17%, LNZA is in the better half of the industry, outperforming 75.31% of the companies in the same industry.
LNZA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

LNZA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LNZA has more shares outstanding
LNZA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

LNZA has an Altman-Z score of -5.74. This is a bad value and indicates that LNZA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of LNZA (-5.74) is worse than 92.59% of its industry peers.
LNZA has a Debt/Equity ratio of 4.53. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of LNZA (4.53) is worse than 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.53
Debt/FCF N/A
Altman-Z -5.74
ROIC/WACCN/A
WACC9.24%

2.3 Liquidity

LNZA has a Current Ratio of 2.91. This indicates that LNZA is financially healthy and has no problem in meeting its short term obligations.
LNZA has a Current ratio of 2.91. This is amongst the best in the industry. LNZA outperforms 81.48% of its industry peers.
LNZA has a Quick Ratio of 2.91. This indicates that LNZA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.91, LNZA belongs to the top of the industry, outperforming 87.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.91
Quick Ratio 2.91

4

3. Growth

3.1 Past

LNZA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.02%, which is quite impressive.
The Revenue has grown by 37.57% in the past year. This is a very strong growth!
EPS 1Y (TTM)33.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-123.08%
Revenue 1Y (TTM)37.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-49.28%

3.2 Future

Based on estimates for the next years, LNZA will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.07% on average per year.
The Revenue is expected to grow by 18.61% on average over the next years. This is quite good.
EPS Next Y16.26%
EPS Next 2Y24.23%
EPS Next 3Y14.07%
EPS Next 5YN/A
Revenue Next Year-22.45%
Revenue Next 2Y25.28%
Revenue Next 3Y18.61%
Revenue Next 5YN/A

3.3 Evolution

0

4. Valuation

4.1 Price/Earnings Ratio

LNZA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LNZA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

LNZA's earnings are expected to grow with 14.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.23%
EPS Next 3Y14.07%

0

5. Dividend

5.1 Amount

LNZA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LANZATECH GLOBAL INC

NASDAQ:LNZA (1/6/2025, 8:00:00 PM)

Premarket: 2.07 +0.14 (+7.25%)

1.93

+0.25 (+14.88%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)N/A N/A
Inst Owners68.35%
Inst Owner Change0%
Ins Owners2.12%
Ins Owner Change0%
Market Cap381.72M
Analysts82
Price Target3.83 (98.45%)
Short Float %5.01%
Short Ratio8.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-80.4%
Min EPS beat(2)-141.46%
Max EPS beat(2)-19.35%
EPS beat(4)0
Avg EPS beat(4)-43.5%
Min EPS beat(4)-141.46%
Max EPS beat(4)-1.15%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-12.47%
Min Revenue beat(2)-45.67%
Max Revenue beat(2)20.73%
Revenue beat(4)1
Avg Revenue beat(4)-20.19%
Min Revenue beat(4)-45.67%
Max Revenue beat(4)20.73%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-27.56%
EPS NY rev (1m)-8.12%
EPS NY rev (3m)-37.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-33.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-29.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.58
P/FCF N/A
P/OCF N/A
P/B 28.06
P/tB 28.06
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS0.29
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -59.85%
ROE -951.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.17%
FCFM N/A
ROA(3y)-19.35%
ROA(5y)N/A
ROE(3y)-40.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 4.53
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 86.27%
Cap/Sales 8.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.91
Quick Ratio 2.91
Altman-Z -5.74
F-Score3
WACC9.24%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-123.08%
EPS Next Y16.26%
EPS Next 2Y24.23%
EPS Next 3Y14.07%
EPS Next 5YN/A
Revenue 1Y (TTM)37.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-49.28%
Revenue Next Year-22.45%
Revenue Next 2Y25.28%
Revenue Next 3Y18.61%
Revenue Next 5YN/A
EBIT growth 1Y-11.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year23.67%
EBIT Next 3Y8.7%
EBIT Next 5YN/A
FCF growth 1Y-11752.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11098.7%
OCF growth 3YN/A
OCF growth 5YN/A